Wednesday, April 10, 2024
Perspectives /
Press Releases
Read about Verily’s latest news and updates and see how we’re partnering with industry leaders to build the future of precision health.
Thursday, April 4, 2024
Otsuka works with Verily to launch longitudinal mental health registry to advance novel research in psychiatry
Tuesday, April 2, 2024
Bharat Rajagopal Joins Verily as Chief Revenue Officer
Thursday, October 26, 2023
Georgiamune and Verily announce strategic partnership to advance novel cancer treatment
Wednesday, October 4, 2023
Sosei Heptares and Verily nominate first G-protein-coupled receptor target for therapeutic development
Monday, October 2, 2023
U.S. Centers for Disease Control and Prevention Selects Verily to Support National Wastewater Monitoring
Thursday, September 7, 2023
Verily and Kyverna Therapeutics announce collaboration to advance cell therapy for autoimmune diseases
Tuesday, August 1, 2023
Verily Appoints Andrew Trister, MD, PhD as Chief Scientific Officer
Monday, July 10, 2023
The ‘My Skin & Hair Journey’ registry now open for enrollment, seeking self-identifying women participants for U.S. cohort
Wednesday, June 28, 2023
Verily appoints Laura O’Donnell as General Counsel
Wednesday, February 1, 2023
Otsuka and Verily Expand Collaboration on Novel Clinical Trials Solutions to Accelerate Research in Major Depressive Disorder
Tuesday, October 25, 2022
Verily and Crohn’s & Colitis Foundation expand strategic partnership to establish novel registry of patients with inflammatory bowel disease (IBD)
Thursday, September 29, 2022
Verily and Swiss Re Broaden Strategic Relationship
Friday, September 9, 2022
Verily Announces $1 Billion Investment Round to Fund Continued Growth and Shares Changes to Leadership Team
Wednesday, August 17, 2022
Onduo by Verily and Sword Health partner to accelerate adoption of comprehensive, precision care approach
Wednesday, March 16, 2022
Verily and Lumea Announce Development Partnership to Advance Digital Pathology in Prostate Cancer
Tuesday, February 22, 2022
Highmark Health launches diabetes management program with Onduo by Verily
Thursday, January 6, 2022
Sosei Heptares and Verily will collaborate to generate novel drug candidates against GPCR targets for immune-mediated diseases
Thursday, October 14, 2021
Verily Accelerates Technology and Commercial Growth with New Operations Hub in Dallas
Thursday, September 30, 2021
Onduo and Fitbit collaborate to provide Onduo members with Fitbit devices and services to help manage their holistic health
Tuesday, August 31, 2021
Verily Completes Acquisition of SignalPath, Expanding Company's Clinical Research Capabilities and Marking Company's First Major Acquisition
Thursday, August 26, 2021
Mayo Clinic, Verily to build advanced clinical decision support to enhance care
Tuesday, August 17, 2021
Verily to Acquire SignalPath, Expanding Company's Clinical Research Capabilities
Friday, August 6, 2021
Colgate-Palmolive to Leverage Verily’s Baseline Platform for Innovative Study in Oral Health Research
Thursday, August 5, 2021
Verily Opens New R&D Center in Israel Focused on the Application of AI in Healthcare
Thursday, June 3, 2021
Verily Appoints Health Data Expert and Former FDA Principal Deputy Commissioner Amy Abernethy, MD, PhD as President of Verily's Clinical Research Platforms
Tuesday, May 25, 2021
Verily Appoints Industry HR Leader Kerrie Peraino as Chief People Officer
Tuesday, April 27, 2021
Verily Enhances Commercial Organization with the Appointment of Lisa Greenbaum as Chief Revenue Officer
Monday, April 5, 2021
With New Name and Leader, Verily/ResMed Joint Venture Poised to Shine Light on America's Sleep Health Crisis
Thursday, April 1, 2021
Morehouse College Announces $575,000 Endowed Life Sciences Scholarship from Verily
Monday, March 15, 2021
Granular Insurance Company (previously Coefficient Insurance Company), Verily, and Swiss Re Corporate Solutions Close Investment Transaction
Tuesday, March 2, 2021
Highmark Health engages Verily to reinvent the healthcare experience for Highmark Health customers and clinicians
Thursday, December 17, 2020
Verily Announces $700 Million Investment Round to Accelerate Key Businesses, Including Baseline and Verily Health Platforms
Tuesday, September 15, 2020
Atlanta University Center Consortium (AUCC) provides its colleges with integrated COVID-19 testing, symptom screening and data analytics through Verily’s Healthy at Work program
Monday, August 24, 2020
Announcing Coefficient, a Verily Subsidiary Focused on Employer Stop-Loss and Backed by Swiss Re Corporate Solutions
Thursday, July 30, 2020
Verily Announces New Customers and Partners for its Healthy at Work Program
Thursday, June 18, 2020
Verily Launches Healthy at Work Program to Support Organizations In Their Efforts to Ensure a Safe Return to Work and School
Monday, December 23, 2019
Verily Partners with Emory Healthcare to Analyze Medication and Lab Ordering Patterns for Improved Cost-Effectiveness and Operational Efficiency
Tuesday, May 21, 2019
Verily Forms Strategic Alliances with Novartis, Otsuka, Pfizer and Sanofi to Transform Clinical Research
Thursday, May 16, 2019
Verily launches Baseline Health System Consortium with Vanguard Health Systems
Tuesday, February 26, 2019
The American Heart Association’s Go Red for Women and Verily’s Project Baseline Collaborate to Include More Women in Scientific Research
Wednesday, December 19, 2018
Walgreens Boots Alliance and Verily Announce Strategic Partnership to Innovate on New Solutions to Improve Health Outcomes
Wednesday, July 11, 2018
ResMed, Verily to Form Joint Venture to Help Reach Millions of Untreated Sleep Apnea Sufferers
Monday, April 30, 2018
Gilead and Verily Announce Scientific Collaboration to Identify and Understand Immunological and Molecular Drivers of Inflammatory Diseases
Friday, January 6, 2017
Verily Announces $800M Investment by Temasek
Monday, December 5, 2016
Verily Life Sciences Launches Liftware Level Device to Help People with Limited Hand and Arm Mobility Eat with Confidence
Monday, September 12, 2016
Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform
More about Verily
